CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4734)
EKR Therapeutics is a specialty pharmaceutical company committed to serving the acute-care hospital setting by identifying, commercializing, and marketing products to address unmet or undersatisfied medical needs. The company's product offerings incl...Show all
Company (Acquired)
Phone: 877-435-2524
1545 US Highway 206
Third Floor
Bedminster, 07921
New Jersey, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| EKR Therapeutics | $160M | May 16, 2012 |
| Abaxis | $14.1M | May 16, 2018 |
| Debiotech SA | $0M | Feb 20, 2019 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compositions of nicardipine and sulfoalkylated β-cyclodextrin | Sep 18, 2013 | Jan 24, 2017 | Patent |
| Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions | Dec 23, 2010 | Jun 21, 2016 | Patent |
| Pre-mixed, ready-to-use pharmaceutical compositions | Dec 22, 2009 | Jun 14, 2016 | Patent |
| Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Dec 17, 2010 | Jun 04, 2013 | Patent |
| Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions | Mar 19, 2009 | Feb 09, 2010 | Patent |
